Roger Chih Chieh Chang
About Roger Chih Chieh Chang
Roger Chih Chieh Chang is a Senior Manager of Biostatistics at Inari Medical, with extensive experience in biostatistics and risk consulting across various organizations in the pharmaceutical and healthcare sectors.
Current Role at Inari Medical
Roger Chih Chieh Chang currently serves as Senior Manager of Biostatistics at Inari Medical, a position he has held since 2022. In this role, he is responsible for overseeing biostatistical activities related to clinical studies and real-world evidence. His expertise contributes to the design and analysis of clinical trials, ensuring compliance with regulatory standards. Previously, he worked as Manager of Biostatistics at Inari Medical from 2021 to 2022, where he gained valuable experience in the pharmaceutical and healthcare sectors.
Previous Experience in Biostatistics and Analytics
Before his tenure at Inari Medical, Roger Chang held several significant positions in biostatistics and analytics. He was a Principal Analyst in Statistical Programming at Biogen from 2020 to 2021, where he focused on statistical methodologies for clinical trials. Prior to that, he worked as a Lead Risk Consultant and Assistant Director at Moody's Analytics from 2018 to 2020, applying his analytical skills in risk assessment. His background also includes roles at the University of Southern California, where he served as a Senior Research Associate and Research Analyst.
Educational Background and Qualifications
Roger Chang has a robust educational background in mathematics, finance, and statistics. He earned a Bachelor of Science in Mathematics and a Bachelor of Business Administration from National Chung Cheng University, both completed in 2000. He furthered his studies with a Master of Arts in Statistics from Columbia University in 2004 and an MBA in Management Science from National Chiao Tung University in 2002. He holds a PhD in Biostatistics from the University of Southern California, which enhances his expertise in statistical analysis and clinical study design.
Expertise in Real World Evidence and Clinical Study Design
Roger Chang has a demonstrated history of working in Real World Evidence and clinical study design within the pharmaceutical and healthcare industry. His experience includes developing statistical models and conducting analyses that support clinical research initiatives. He possesses strong skills in analytical programming, utilizing tools such as SAS, R, and WinBugs, which are essential for data analysis and interpretation in clinical trials.
Career Development and Early Experience
Roger Chang began his career as a Research Assistant at the University of Southern California, where he worked for ten years from 2005 to 2015. He also gained experience as a Summer Student Statistician at the House Ear Institute in 2005. Following his academic roles, he transitioned to the financial sector as a Quantitative Analyst at Bank of the West from 2015 to 2018, where he developed models for risk assessment and financial reporting.